Medecine et Maladies Infectieuses

Aims & Scope

L'organe d'expression de la Société de Pathologie Infectieuse de Langue Française (SPILF).

Médecine et Maladies Infectieuses is the official publication of the Société de Pathologie Infectieuse de Langue Française (SPILF).

Médecine et Maladies Infectieuses is indexed in the major databases: Medline, Web of Science/Clarivate and Scopus.

The journal publishes scientific /research articles, general reviews, short communications and letters, in both English and French.

The journal welcomes submissions on the various aspects of infectious pathologies and pathogenic agents.

Médecine et Maladies Infectieuses focuses on clinical therapeutics, nosocomial infections, biology, prevention, as well as epidemiology and therapeutics.

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection

  Citation: 537

  Authors: J.M., C., J., B., D., L., N.

• C-reactive protein levels in the early stage of COVID-19

  Citation: 463

  Authors: L.

• Current Zika virus epidemiology and recent epidemics

  Citation: 438

  Authors: S., H.-P., I., V., T., M.

• Probiotics, gut microbiota and health

  Citation: 336

  Authors: M.-J.

• Features of anosmia in COVID-19

  Citation: 321

  Authors: T., N.J., L., P.-Y., Q., V., S.

• Diagnosis and epidemiology of leptospirosis

  Citation: 255

  Authors: M.

• Interleukin-6 as a potential biomarker of COVID-19 progression

  Citation: 242

  Authors: Zulvikar Syambani, Gita Vita

• Targeting mechanisms of Pseudomonas aeruginosa pathogenesis

  Citation: 233

  Authors: E., T., J.

• Phage therapy experience at the Eliava Institute

  Citation: 208

  Authors: M., R.

• Carbapenemase-producing Enterobacteriaceae: Overview of a major public health challenge

  Citation: 200

  Authors: P.